PMID: 6540405Sep 1, 1984Paper

Western Norway, a high-risk area for multiple sclerosis: a prevalence/incidence study in the county of Hordaland

Neurology
J P LarsenT Riise

Abstract

Prevalence studies and investigations based on death certificates and disability assistance have shown that western Norway has been a medium-frequency area for MS. The prevalence of definite/probable MS on January 1, 1963 was 20.1/100,000. Based on the same diagnostic criteria, the prevalence of definite/probable MS had increased to 59.8/100,000 on January 1, 1983 in the county of Hordaland. We consider this increase of MS cases in the population to be due to real biologic changes, although factors affecting the figures were found. Most important was a reduction in the interval from onset to diagnosis. The rise in prevalence was also supported by an increase in the annual incidence of the disease. The incidence rate averaging 2 per 100,000 in the period 1953 to 1962 rose to 3.5 for 1968 to 1977. This marked rise in prevalence/incidence supports the concept that an exogenous factor is important in the pathogenesis of MS.

Citations

Sep 1, 1995·Movement Disorders : Official Journal of the Movement Disorder Society·E TandbergJ A Aarli
Nov 17, 2007·Journal of Neurology·E GranieriI Casetta
Mar 10, 2001·Acta Neurologica Scandinavica·M L SumelahtiM Hakama
Mar 1, 1993·Journal of Sleep Research·H SchraderT Sand
Mar 1, 1991·Acta Neurologica Scandinavica·S PoserF A Stichnoth
Dec 18, 2002·Journal of Neurology, Neurosurgery, and Psychiatry·M-L SumelahtiJ Wikström
Aug 12, 2014·International Journal of Developmental Neuroscience : the Official Journal of the International Society for Developmental Neuroscience·Claude M J Braun, Carl Roberge
Mar 1, 1988·Journal of Neurology·H Meyer-Rienecker, F Buddenhagen
Nov 11, 2005·Acta Psychiatrica Scandinavica·N FigvedD Aarsland
Jan 4, 2013·Acta Neurologica Scandinavica. Supplementum·R Midgard
Dec 18, 2009·Acta Neurologica Scandinavica·Poul Joensen
Jan 1, 1988·Journal of Clinical Epidemiology·T RiiseA Edland
Jan 1, 1986·Journal of Chronic Diseases·K Lauer, W Firnhaber
Sep 1, 1989·APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica·L R HaaheimH Nyland
Jan 23, 2008·Multiple Sclerosis : Clinical and Laboratory Research·E GranieriI Casetta
Jul 18, 2008·Multiple Sclerosis : Clinical and Laboratory Research·N Grytten TorkildsenK M Myhr
Sep 14, 2001·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·E G Celius, B Vandvik
Apr 11, 2007·Acta Neurologica Scandinavica. Supplementum·Ø TorkildsenK-M Myhr
Aug 1, 1984·Acta Neurologica Scandinavica·J P LarsenJ A Aarli
Aug 1, 1985·Acta Neurologica Scandinavica·J P LarsenJ A Aarli
Mar 1, 1985·Acta Neurologica Scandinavica·J P LarsenJ A Aarli
Jun 1, 1996·Acta Neurologica Scandinavica·R MidgardH Nyland
May 1, 1985·Acta Neurologica Scandinavica·J P LarsenJ A Aarli
Jan 1, 1985·Acta Neurologica Scandinavica·J P LarsenH Nyland
May 1, 1996·Acta Neurologica Scandinavica·R MidgardH Nyland
Feb 1, 1993·The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques·A D Sadovnick, G C Ebers
Sep 1, 1985·Acta Neurologica Scandinavica·M Grønning, S I Mellgren
May 1, 1996·Acta Neurologica Scandinavica·R MidgardH Nyland
Oct 1, 1993·Clinical Microbiology Reviews·J F Kurtzke

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.